XML 31 R7.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Cash Flows - USD ($)
12 Months Ended
Jan. 30, 2021
Feb. 01, 2020
Feb. 02, 2019
Operating activities      
Net (loss) income $ (108,954,000) $ 44,960,000 $ 78,808,000
Adjustments to reconcile net (loss) income to net cash provided by operating activities      
Depreciation and amortization 166,281,000 173,625,000 178,030,000
Asset impairment 72,937,000 22,364,000 11,580,000
Loss on disposal 16,353,000 6,298,000 6,020,000
Deferred lease credits amortization 0 0 (21,320,000)
Provision for deferred income taxes 23,986,000 9,150,000 5,946,000
Share-based compensation 18,682,000 14,007,000 21,755,000
Changes in assets and liabilities      
Inventories 33,312,000 2,270,000 (23,820,000)
Accounts payable and accrued expenses 186,747,000 10,821,000 63,155,000
Increase decrease in operating lease liabilities (55,700,000) 46,442,000 0
Income taxes 10,753,000 (5,473,000) 5,409,000
Other assets 38,632,000 (20,137,000) 33,302,000
Other liabilities 1,889,000 (3,642,000) (5,932,000)
Net cash provided by operating activities 404,918,000 300,685,000 352,933,000
Investing activities      
Purchases of property and equipment (101,910,000) (202,784,000) (152,393,000)
Net cash used for investing activities (51,910,000) (202,784,000) (152,393,000)
Financing activities      
Purchases of common stock (15,172,000) (63,542,000) (68,670,000)
Repayments of Lines of Credit (233,250,000) (20,000,000) 0
Dividends paid (12,556,000) (51,510,000) (53,714,000)
Other financing activities (11,987,000) (12,821,000) (9,307,000)
Net cash provided by (used for) financing activities 69,717,000 (147,873,000) (131,691,000)
Effect of foreign currency exchange rates on cash 9,168,000 (3,593,000) (20,975,000)
Net increase (decrease) in cash and equivalents, and restricted cash and equivalents 431,893,000 (53,565,000) 47,874,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1,124,157,000 692,264,000 745,829,000
Supplemental information related to non-cash activities      
Purchases of property and equipment not yet paid at end of period 16,250,000 44,199,000 17,299,000
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability (38,279,000) 391,753,000 0
Supplemental information related to cash activities      
Cash paid for interest 26,629,000 17,514,000 14,221,000
Cash paid for income taxes 15,210,000 20,717,000 24,331,000
Cash received from income tax refunds 4,650,000 8,773,000 9,631,000
Operating Lease, Payments 316,992,000 422,850,000 0
Withdrawal from Rabbi Trust Assets 50,000,000 0 0
Net Income (Loss), Including Portion Attributable to Noncontrolling Interest (108,954,000) 44,960,000 78,808,000
Depreciation, Depletion and Amortization, Nonproduction 166,281,000 173,625,000 178,030,000
Restructuring Costs and Asset Impairment Charges 72,937,000 22,364,000 11,580,000
Gain (Loss) on Disposition of Property Plant Equipment (16,353,000) (6,298,000) (6,020,000)
Deferred lease credits amortization 0 0 21,320,000
Current Deferred Income Tax Expense (Benefit) (23,986,000) (9,150,000) (5,946,000)
Share-based Payment Arrangement, Noncash Expense 18,682,000 14,007,000 21,755,000
Increase (Decrease) in Inventories (33,312,000) (2,270,000) 23,820,000
Increase (Decrease) in Accounts Payable and Accrued Liabilities 186,747,000 10,821,000 63,155,000
Increase decrease in operating lease liabilities (55,700,000) 46,442,000 0
Increase (Decrease) in Income Taxes Payable 10,753,000 (5,473,000) 5,409,000
Increase (Decrease) in Other Operating Assets (38,632,000) 20,137,000 (33,302,000)
Other liabilities 1,889,000 (3,642,000) (5,932,000)
Net Cash Provided by (Used in) Operating Activities 404,918,000 300,685,000 352,933,000
Payments to Acquire Property, Plant, and Equipment 101,910,000 202,784,000 152,393,000
Withdrawal from Rabbi Trust Assets 50,000,000 0 0
Net Cash Provided by (Used in) Investing Activities (51,910,000) (202,784,000) (152,393,000)
Repayments of Lines of Credit 233,250,000 20,000,000 0
Payments for Repurchase of Common Stock 15,172,000 63,542,000 68,670,000
Payments of Ordinary Dividends, Common Stock 12,556,000 51,510,000 53,714,000
Change in Outstanding Checks and Other 11,987,000 12,821,000 9,307,000
Net Cash Provided by (Used in) Financing Activities 69,717,000 (147,873,000) (131,691,000)
Effect of Exchange Rate on Cash and Cash Equivalents 9,168,000 (3,593,000) (20,975,000)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 431,893,000 (53,565,000) 47,874,000
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 1,124,157,000 692,264,000 745,829,000
Construction in Progress Expenditures Incurred but Not yet Paid 16,250,000 44,199,000 17,299,000
Right-of-Use Asset Obtained in Exchange for Operating Lease Liability (38,279,000) 391,753,000 0
Cash paid for interest 26,629,000 17,514,000 14,221,000
Cash paid for income taxes 15,210,000 20,717,000 24,331,000
Cash received from income tax refunds 4,650,000 8,773,000 9,631,000
Operating Lease, Payments 316,992,000 422,850,000 0
Proceeds from Notes Payable 350,000,000 0 0
Proceeds from Short-term Debt 210,000,000 0 0
Repayments of Short-term Debt (210,000,000) 0 0
Payments of Debt Issuance Costs $ (7,318,000) $ 0 $ 0